dr. patrick forde discusses 3-year checkmate 816 nsclc results at asco 2023
Published 1 year ago • 276 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
2:04
dr. patrick m. forde on neoadjuvant dr. patrick m. forde on neoadjuvant nivolumab in nsclc
-
5:12
dr. ruben mesa discusses asco 2023 updates from the simplify trials in myelofibrosis
-
1:54
varian edge for brain cancer
-
40:07
cushings disease: current management - nelson oyesiku, md, phd.
-
11:54
a leap forward in rare disease treatment
-
55:19
this is your brain: advances in metastatic brain tumor treatment
-
28:30
episode 4 - proton therapy
-
2:47
6-year-old completes final proton therapy cancer treatment
-
4:17
neuroendocrine cancer symptoms: full interview with prof nick pavlakis
-
6:48
durvalumab improves pfs in stage iii lung cancer
-
1:21:50
ep 194 subarachnoid hemorrhage – recognition, workup and diagnosis deep dive
-
1:01:16
consilience: the albert stroberg lecture series featuring dr. byron ford
-
1:31
michelle kaplinski, md - stanford medicine children's health
-
1:11
grade 3 anaplastic astrocytoma
-
2:11
immunotherapy, explained by dr. evan yu
-
2:48
a deeper understanding
-
5:42
udall center for parkinson's disease research: emory university
-
2:43
15 prognosis
-
2:17
breakthrough lung cancer drug to be added to the pbs